Palladone (Hydromorphone Hydrochloride)

Hydromorphone Hydrochloride, the active ingredient in Palladone, is an opioid analgesic presented as a strength/form for oral use. It treats moderate to severe pain, particularly when other analgesics are insufficient, and is prescribed for adult patients. GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Palladone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Palladone is an opioid analgesic that acts on the central nervous system to manage pain.

- Acute postoperative pain: Provides rapid relief of pain following surgery. - Cancer‑related pain: Improves analgesia in patients with malignant disease. - Severe chronic pain: Offers long‑term control for persistent severe pain when other opioids are inadequate.

Hydromorphone may elicit a range of adverse reactions, from mild to potentially life‑threatening.

Common Side Effects: - Nausea and vomiting. - Constipation. - Drowsiness or sedation. - Dry mouth. - Sweating. - Itching (pruritus).

Serious or Rare Side Effects: - Respiratory depression. - Severe hypotension. - Bradycardia. - Allergic reactions such as angio‑angulation. - Seizure activity. - Dependence, tolerance and withdrawal syndrome.

When ​  ​       ​  ​  …  …   … ...  … … … ... … … … …  … … … … …  … … …